Singulair and Chest wall mass - a phase IV clinical study of FDA data
Summary:
Chest wall mass is reported as a side effect among people who take Singulair (montelukast sodium), especially for people who are female, 50-59 old, also take Levaquin, and have Breast cancer.
The phase IV clinical study analyzes which people have Chest wall mass when taking Singulair. It is created by eHealthMe based on reports of 125,532 people who have side effects when taking Singulair from the FDA, and is updated regularly.
What is Singulair?
Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.
What is Chest wall mass?
Chest wall mass is found to be associated with 153 drugs and 144 conditions by eHealthMe. Check the latest studies of Chest wall mass.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
125,532 people reported to have side effects when taking Singulair.
Among them, 18 people (0.01%) have Chest wall mass.

Among these 18 people:
What is the gender of people who have Chest wall mass when taking Singulair? *
- female: 94.44 %
- male: 5.56 %
What is the age of people who have Chest wall mass when taking Singulair? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 94.12 %
- 60+: 5.88 %
What are other drugs people take besides Singulair? *
- Zometa: 17 people, 94.44%
- Oxycontin: 17 people, 94.44%
- Neurontin: 17 people, 94.44%
- Ms Contin: 17 people, 94.44%
- Morphine: 17 people, 94.44%
- Methocarbamol: 17 people, 94.44%
- Lyrica: 17 people, 94.44%
- Lidoderm: 17 people, 94.44%
- Lexapro: 17 people, 94.44%
- Levaquin: 17 people, 94.44%
What are other side effects people have besides Chest wall mass? *
- Abdominal Fullness Prematurely After Meals: 17 people, 94.44%
- Hypomania (a mild form of mania, marked by elation and hyperactivity): 17 people, 94.44%
- Hand Fracture: 17 people, 94.44%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 17 people, 94.44%
- Hepatic Cyst: 17 people, 94.44%
- Cardiac Failure Congestive: 17 people, 94.44%
- Hip Fracture: 17 people, 94.44%
- Hyperkeratosis (thickening of the outer layer of the skin): 17 people, 94.44%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 17 people, 94.44%
- Breast Cancer Recurrent: 17 people, 94.44%
What are the existing conditions these people have? *
- Breast Cancer: 8 people, 44.44%
- Osteoporosis (bones weak and more likely to break): 4 people, 22.22%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 22.22%
- Metastases To Bone (cancer spreads to bone): 4 people, 22.22%
- Sleep Disorder: 1 person, 5.56%
- Nervousness: 1 person, 5.56%
- Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 5.56%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.56%
- High Blood Pressure: 1 person, 5.56%
- Arrhythmias (irregular heartbeat): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Singulair and have Chest wall mass?
- Check whether Chest wall mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Singulair:
- Singulair (129,752 reports)
Chest wall mass treatments and more:
- Chest wall mass (395 reports)
How severe was Chest wall mass and when was it recovered:
Expand to all the drugs that have ingredients of montelukast sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Singulair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chest wall mass:
- Chest wall mass (153 drugs)
Browse all the conditions that are associated with Chest wall mass:
- Chest wall mass (144 conditions)
Related publications that referenced our studies
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Singulair) and Singulair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Synthroid and Diabetic Ketoacidosis for Men aged 50-59 - 10 seconds ago
- Synthroid and Dka for Men aged 50-59 - 10 seconds ago
- Synthroid and Diabetic Coma for Men aged 50-59 - 10 seconds ago
- Synthroid and Ketoacidosis for Men aged 50-59 - 11 seconds ago
- Ambien and Slurred Speech for Men aged 50-59 - 22 seconds ago
- Ambien and Language Impairment for Men aged 50-59 - 22 seconds ago
- Ambien and Inability To Speak for Men aged 50-59 - 23 seconds ago
- Ambien and Impairment Of Speech for Men aged 50-59 - 23 seconds ago
- Ambien and Dysphasia for Men aged 50-59 - 23 seconds ago
- Ambien and Dysarthria for Men aged 50-59 - 24 seconds ago